Secondary prevention of cardioembolic stroke: oldest and newest promises (Q36533176)

14 August 2017

1 reference

title

Secondary prevention of cardioembolic stroke: oldest and newest promises (English)

1 reference

14 August 2017

Corea F

1

1 reference

14 August 2017

Spinelli M

2

1 reference

14 August 2017

Tambasco N

3

1 reference

14 August 2017

Silvestrelli G

4

1 reference

14 August 2017

Parnetti L

5

1 reference

14 August 2017

publication date

1 April 2006

1 reference

Clinical and Experimental Hypertension

14 August 2017

published in

1 reference

14 August 2017

volume

28

1 reference

14 August 2017

issue

3-4

1 reference

14 August 2017

page(s)

413-420

1 reference

Heart-brain relationship: atrial fibrillation and stroke

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Warfarin for atrial fibrillation: the end of an era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549900

10.1080/10641960600549900

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference